Delivery Order HHSD200201141272I-HHSD2002011412720001
Award Date
9/29/11
Potential Completion Date
9/28/21
Potential Value
$3.1M
Federal Agency
CDC Pittsburgh
Awardee
University Of Florida
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
10
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
The University of Florida (UF) Division of Sponsored Research was awarded a Firm Fixed Price Delivery Order contract from the Office of Acquisitions and Grants, a civilian federal agency, with a ceiling value of $1,624. The contract, which does not have a set-aside designation, is for Task Order 8 under a larger Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID). This IDC, valued at $146.3 million over 7 years, supports the development and...
This federal contract with award ID 75D30122C15503 was awarded to the University of Florida Division of Sponsored Research by the Centers for Disease Control and Prevention (CDC) on September 30, 2022. The $748,553.00 firm fixed-price definitive contract is for the "EVALUATION OF EMERGING INFECTIONS DURING PREGNANCY AND THEIR PREVENTION AND" and has a period of performance through March 28, 2025. The contract has no set-aside designation. The University of Florida is a major research...
The University of Florida (UF) Division of Sponsored Research has been awarded a Firm Fixed Price Delivery Order contract by the Office of Acquisitions and Grants, a civilian agency, with a ceiling value of $2,072.00. The contract, Task Order 9 Modification G0321D0007, has an ultimate completion date of January 20, 2025. This contract award is not associated with any set-aside designation. UF, a major research institution, has a broad portfolio of federal contract and grant awards supporting...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price definitive contract to the University of Florida's Division of Sponsored Research, a public land-grant research university, for $690,664.00. The contract is for the development of a smart bioassay cage system with environmental sensors and aerosol monitoring capabilities to support mosquito field testing and evaluation. The University of Florida is partnering with the Anastasia...
The University of Florida's Division of Sponsored Research was awarded a firm fixed price, definite contract valued at one million five hundred forty-three thousand one hundred fifty-three dollars and eighty cents ($1,543,153.80) by the Department of Health and Human Services' Food and Drug Administration. The contract has no set-aside designation. It will support a pharmacokinetics study with performance taking place in Gainesville, Florida through April 2020. As a leading public research...
The Department of Health and Human Services Food and Drug Administration awarded a $226,675.52 firm fixed-price definitive contract to the University of Florida's Division of Sponsored Research to conduct a randomized, controlled clinical trial in critically ill patients with severe pneumonia receiving beta-lactam therapy as continuous versus intermittent infusion for Gram-negative infections, and assess the development of new bacteria. This contract was awarded under the FDA's Broad Agency...
This is a $500,000 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research for a pharmacokinetic comparison study of locally acting orally inhaled drug products. The contract does not have a set-aside designation, indicating UF competed for and was awarded the contract based on its extensive research capabilities. UF is a major research institution that provides a wide range of goods and services to...
The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...